Intranasal Mitochondria-Targeted Rosmarinic Acid Selenium Nanoparticles Restore Mitochondrial Function and Attenuate Dopaminergic Neurodegeneration in Parkinson’s Disease
ACS Applied Materials & Interfaces · 29.10.2026
DOI: 10.1021/acsami.6c16278 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 29.10.2026. Verfasst von Gajanan Balaji Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. A Transit Campus at Bijnor-Sisendi Road,…. Die Arbeit nennt 99 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss, mitochondrial dysfunction, oxidative stress, and α-synuclein pathology, highlighting the need for mitochondria-targeted neuroprotective strategies. Here, we developed a mitochondria-targeted intranasal nanotherapeutic system comprising rosmarinic acid (RA)-loaded selenium nanoparticles (RASNPs) surface-functionalized with triphenylphosphonium (TPP)-conjugated chitosan (TCS-RASNPs) to enhance nose-to-brain delivery and improve mitochondrial function. TCS-RASNPs exhibited a spherical morphology, a uniform particle size distribution (140.13 ± 0.40 nm), a narrow polydispersity, and a positive surface charge (33.7 ± 0.75 mV), indicating good colloidal stability. Spectroscopic characterization confirmed successful RA loading and surface functionalization. Moreover, TCS-RASNPs enhanced antioxidant activity and sustained drug release compared with free RA and unmodified RASNPs. In neuronal cells, TCS-RASNPs significantly enhanced neuronal survival, reduced apoptosis, attenuated intracellular and mitochondrial reactive oxygen species (ROS) generation, and improved mitochondrial membrane potential under 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity. Confocal microscopy further confirmed efficient mitochondrial localization of TCS-RASNPs. Pharmacokinetic and biodistribution studies demonstrated prolonged retention of RA and significantly higher brain RA levels following intranasal administration. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonian mice, TCS-RASNPs increased tyrosine hydroxylase (TH) expression, reduced α-synuclein (SNCA) expression, and normalized oxidative stress biomarkers in the substantia nigra pars compacta (SNpc) and striatum (STR) regions. Together, these findings demonstrate that TCS-RASNPs facilitate mitochondrial targeting and nose-to-brain delivery, thereby representing a promising nanotherapeutic approach for the management of PD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. A Transit Campus at Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow, Uttar Pradesh226002, In…
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. A Transit Campus at Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow, Uttar Pra…
ORCID-Profile: Anjuman Nanda, Awesh K Yadav
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Paul, G. B., Nanda, A., Singh, R. K., & Yadav, A. K. (2026). Intranasal Mitochondria-Targeted Rosmarinic Acid Selenium Nanoparticles Restore Mitochondrial Function and Attenuate Dopaminergic Neurodegeneration in Parkinson’s Disease. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c16278
Vancouver
Paul GB, Nanda A, Singh RK, Yadav AK. Intranasal Mitochondria-Targeted Rosmarinic Acid Selenium Nanoparticles Restore Mitochondrial Function and Attenuate Dopaminergic Neurodegeneration in Parkinson’s Disease. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c16278
BibTeX
@article{Paul2026,
author = {Paul, Gajanan Balaji and Nanda, Anjuman and Singh, Rakesh K and Yadav, Awesh K},
title = {Intranasal Mitochondria-Targeted Rosmarinic Acid Selenium Nanoparticles Restore Mitochondrial Function and Attenuate Dopaminergic Neurodegeneration in Parkinson’s Disease},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c16278}
}
EUVIMED